Molecular prediction of oseltamivir efficiency against probable influenza A (H1N1-2009) mutants: molecular modeling approach

[1]  Thanyada Rungrotmongkol,et al.  Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. , 2009, Biochemical and biophysical research communications.

[2]  Dominik Gront,et al.  The crystal structure of the AF2331 protein from Archaeoglobus fulgidus DSM 4304 forms an unusual interdigitated dimer with a new type of α + β fold , 2009, Protein science : a publication of the Protein Society.

[3]  Vasiliy P. Mishin,et al.  Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors , 2005, Antimicrobial Agents and Chemotherapy.

[4]  Guy Boivin,et al.  Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors. , 2002, Antiviral research.

[5]  Thanyada Rungrotmongkol,et al.  Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation , 2009, Amino Acids.

[6]  Arieh Warshel,et al.  A surface constrained all‐atom solvent model for effective simulations of polar solutions , 1989 .

[7]  J. Aqvist,et al.  A new method for predicting binding affinity in computer-aided drug design. , 1994, Protein engineering.

[8]  Thanyada Rungrotmongkol,et al.  How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants? , 2009, Biophysical chemistry.

[9]  Ling-Yun Wu,et al.  Prediction of palmitoylation sites using the composition of k-spaced amino acid pairs. , 2009, Protein engineering, design & selection : PEDS.

[10]  R. Webster,et al.  Neuraminidase Inhibitor-Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity In Vitro and In Vivo , 2007, Journal of Virology.

[11]  Jie J. Zheng,et al.  Computational studies of H5N1 influenza virus resistance to oseltamivir , 2009, Protein science : a publication of the Protein Society.

[12]  B. Lina,et al.  Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  Janet Daly,et al.  Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro. , 2006, The Journal of antimicrobial chemotherapy.

[14]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[15]  Thanyada Rungrotmongkol,et al.  Understanding of known drug‐target interactions in the catalytic pocket of neuraminidase subtype N1 , 2008, Proteins.

[16]  G. Boivin,et al.  Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes. , 2008, Antiviral research.

[17]  Alan J. Hay,et al.  Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants , 2008, Nature.

[18]  Johan Åqvist,et al.  Ligand binding affinity prediction by linear interaction energy methods , 1998, J. Comput. Aided Mol. Des..

[19]  M G Ford,et al.  Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method. , 1999, Journal of medicinal chemistry.

[20]  J. Åqvist,et al.  Q: a molecular dynamics program for free energy calculations and empirical valence bond simulations in biomolecular systems. , 1998, Journal of molecular graphics & modelling.

[21]  R. Webster,et al.  Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility , 2005, Antimicrobial Agents and Chemotherapy.

[22]  Ricky Chachra,et al.  Origins of Resistance Conferred by the R292K Neuraminidase Mutation via Molecular Dynamics and Free Energy Calculations. , 2008, Journal of chemical theory and computation.